CRBU
Price
$2.37
Change
-$0.11 (-4.44%)
Updated
Jul 24 closing price
Capitalization
220.42M
18 days until earnings call
NTLA
Price
$12.78
Change
-$1.46 (-10.25%)
Updated
Jul 24 closing price
Capitalization
1.48B
6 days until earnings call
Interact to see
Advertisement

CRBU vs NTLA

Header iconCRBU vs NTLA Comparison
Open Charts CRBU vs NTLABanner chart's image
Caribou Biosciences
Price$2.37
Change-$0.11 (-4.44%)
Volume$2.09M
Capitalization220.42M
Intellia Therapeutics
Price$12.78
Change-$1.46 (-10.25%)
Volume$7.33M
Capitalization1.48B
CRBU vs NTLA Comparison Chart in %
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. NTLA commentary
Jul 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Buy and NTLA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2025
Stock price -- (CRBU: $2.37 vs. NTLA: $12.78)
Brand notoriety: CRBU and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 125% vs. NTLA: 139%
Market capitalization -- CRBU: $220.42M vs. NTLA: $1.48B
CRBU [@Biotechnology] is valued at $220.42M. NTLA’s [@Biotechnology] market capitalization is $1.48B. The market cap for tickers in the [@Biotechnology] industry ranges from $309.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRBU and NTLA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 3 TA indicator(s) are bullish while NTLA’s TA Score has 2 bullish TA indicator(s).

  • CRBU’s TA Score: 3 bullish, 4 bearish.
  • NTLA’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than NTLA.

Price Growth

CRBU (@Biotechnology) experienced а +29.51% price change this week, while NTLA (@Biotechnology) price change was +8.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.05%. For the same industry, the average monthly price growth was +18.11%, and the average quarterly price growth was +28.55%.

Reported Earning Dates

CRBU is expected to report earnings on Nov 11, 2025.

NTLA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+6.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.48B) has a higher market cap than CRBU($220M). CRBU YTD gains are higher at: 49.057 vs. NTLA (9.605). CRBU has higher annual earnings (EBITDA): -159.14M vs. NTLA (-530.8M). NTLA has more cash in the bank: 504M vs. CRBU (208M). CRBU has less debt than NTLA: CRBU (26.2M) vs NTLA (119M). NTLA has higher revenues than CRBU: NTLA (45.6M) vs CRBU (9.92M).
CRBUNTLACRBU / NTLA
Capitalization220M1.48B15%
EBITDA-159.14M-530.8M30%
Gain YTD49.0579.605511%
P/E RatioN/AN/A-
Revenue9.92M45.6M22%
Total Cash208M504M41%
Total Debt26.2M119M22%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUNTLA
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 15 days ago
89%
Bearish Trend 26 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WCPIX54.14N/A
N/A
Communication Services UltraSectorProInv
SVACX6.35N/A
N/A
Federated Hermes Strategic Value Div C
VNVCX21.43N/A
N/A
Natixis Vaughan Nelson Mid Cap C
ITYYX69.57N/A
N/A
Invesco Technology Y
AMTZX9.85N/A
N/A
AB All Market Real Return Z

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-4.44%
CRSP - CRBU
63%
Loosely correlated
-3.05%
BEAM - CRBU
56%
Loosely correlated
-5.46%
RXRX - CRBU
54%
Loosely correlated
-2.64%
NTLA - CRBU
53%
Loosely correlated
-10.25%
FATE - CRBU
53%
Loosely correlated
-2.34%
More